Suppr超能文献

COVID-19 对原位神经刺激器患者疼痛控制的影响-一项回顾性研究。

The effect of COVID-19 on pain control in patients with a neurostimulator in situ- a retrospective study.

机构信息

Department of Neurosurgery, Queen's Medical Centre, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK.

出版信息

Acta Neurochir (Wien). 2024 Apr 11;166(1):175. doi: 10.1007/s00701-024-06014-0.

Abstract

BACKGROUND

De-novo chronic neuropathic pain following COVID-19 is widely recognised. However, there are currently no published studies investigating the effect of SARS-CoV-2 infection on patients with pre-existing neuropathic pain who have required spinal cord stimulator (SCS) implantation. Here, the authors aimed to analyse outcomes in their institution's patients who had spinal cord stimulator (SCS) implantation or revision procedures to the system over a 5-year period. Specifically, the short-term and long-term outcomes of patients who contracted COVID-19 during the follow-up period were compared to the control group of patients who did not.

METHOD

Patients included in this study had spinal cord stimulator implantation (de-novo and revision procedures) between 1 January 2017 and 31 January 2022, for neuropathic pain of any aetiology. Patients deemed eligible for the study were invited to participate in a telephone survey through which clinical outcome data were collected. Pain scores were assessed with a modified form of the Brief Pain Inventory (BPI).

RESULTS

Of 91 patients, 48 (52.7%) had contracted COVID-19 by the time of the survey. Patients who contracted COVID-19 had significantly worse BPI scores in the 'Least pain' domain following their infection and at time of the survey, when compared to their score 6 months after the operation. 22.9% (n = 11) of the patients who contracted COVID-19 experienced a change in their symptoms following their infection. Within this sub-group, there was a statistically significant deterioration in BPI scores in 10/11 domains following their infection and in 2/11 domains at time of the survey. Worsening severity of COVID-19 symptoms was not associated with worse BPI scores.

CONCLUSIONS

Infection with SARS-CoV-2, in a significant proportion of patients with an SCS in situ, causes at least a transient deterioration in pain control. Further prospective multicentre studies are indicated to establish the prevalence of this phenomenon.

摘要

背景

新冠病毒感染后新发的慢性神经性疼痛已被广泛认识。然而,目前尚无研究调查 SARS-CoV-2 感染对先前存在神经性疼痛且已植入脊髓刺激器(SCS)的患者的影响。在这里,作者旨在分析他们所在机构在 5 年内接受脊髓刺激器(SCS)植入或系统修订手术的患者的结果。具体来说,比较了在随访期间感染 COVID-19 的患者与未感染 COVID-19 的对照组患者的短期和长期结果。

方法

本研究纳入了 2017 年 1 月 1 日至 2022 年 1 月 31 日期间因任何病因导致神经性疼痛而植入脊髓刺激器(初次植入和修订手术)的患者。符合研究条件的患者被邀请通过电话调查参与研究,通过该调查收集临床结果数据。疼痛评分采用简化版简明疼痛量表(BPI)进行评估。

结果

在 91 名患者中,48 名(52.7%)在调查时已感染 COVID-19。与术后 6 个月相比,感染 COVID-19 的患者在“最轻微疼痛”这一维度的 BPI 评分显著更高,且在感染时和调查时的 BPI 评分也更高。22.9%(n=11)的 COVID-19 感染患者在感染后出现症状改变。在这一组亚群中,有 11 个 BPI 评分维度中的 10 个在感染后恶化,有 11 个 BPI 评分维度中的 2 个在调查时恶化。COVID-19 症状严重程度恶化与 BPI 评分恶化无关。

结论

在相当一部分植入 SCS 的患者中,SARS-CoV-2 感染至少会导致疼痛控制暂时恶化。需要进一步开展前瞻性多中心研究来确定这种现象的普遍程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验